Hearing Australia Implements New NAL-NL3 Fitting Prescription
Developed by the National Acoustic Laboratories, the system builds on NAL-NL2 and is designed for more precise, personalized hearing aid fittings.
Developed by the National Acoustic Laboratories, the system builds on NAL-NL2 and is designed for more precise, personalized hearing aid fittings.
This roundtable addresses how hearing care professionals can guide patients in properly using audio devices and hearing protection to safeguard their hearing.
These evidence-based clinical recommendations emphasizing holistic care provide actionable ways for hearing care professionals to address the complex relationship between hearing and cognition in their practices.
Research in children treated for the brain tumor ependymoma finds severe hearing loss is associated with worse intellectual ability and highlights the need for hearing interventions.
The Phase 2 PROHEAR trial is evaluating ACOU085 (Bimokalner) for its efficacy in protecting hearing during chemotherapy.
The partnership makes the bimodal neuromodulation device for tinnitus available through clinics in Philadelphia and Charlotte.
Mead Killion, an audiologist and inventor who died at age 86, is remembered for his contributions to audiology and the hearing industry.
A 14-year-old girl’s vestibular evaluation reveals overlapping signs of vestibular migraine and postural orthostatic tachycardia syndrome (POTS), complicating the diagnosis.
New research shows while overall traffic to low-credibility health sites is low, it is highly concentrated among seniors, particularly those who lean right politically.